Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.17 - $0.74 $1,936 - $8,429
11,391 New
11,391 $2,000
Q2 2022

May 14, 2024

BUY
$0.49 - $1.3 $16,847 - $44,696
34,382 Added 301.83%
45,773 $51,000
Q2 2022

Aug 15, 2022

SELL
$0.49 - $1.3 $8,968 - $23,795
-18,304 Reduced 28.57%
45,773 $51,000
Q1 2022

May 16, 2022

SELL
$1.39 - $3.92 $1.85 Million - $5.21 Million
-1,327,829 Reduced 95.4%
64,077 $89,000
Q4 2021

Feb 14, 2022

BUY
$3.1 - $8.97 $4.28 Million - $12.4 Million
1,380,072 Added 11661.92%
1,391,906 $4.75 Million
Q3 2021

Nov 10, 2021

BUY
$8.35 - $16.99 $98,813 - $201,059
11,834 New
11,834 $105,000

Others Institutions Holding AFIB

# of Institutions
1
Shares Held
3K
Call Options Held
0
Put Options Held
0

About Acutus Medical, Inc.


  • Ticker AFIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,370,300
  • Market Cap $1.7M
  • Description
  • Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conv...
More about AFIB
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.